China grants patent for EntreMed drug

EntreMed Inc., a clinical-stage pharmaceutical company developing drugs for the treatment of cancer, announced it has received a patent from the Chinese State Intellectual Property Office for ENMD-2076, its lead drug candidate.

Leave a Reply

Your email address will not be published. Required fields are marked *